Business
PureTech Presents at Credit Suisse Conference
PureTech Presents at Credit Suisse Conference.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3097E\n PureTech Health PLC\n 05 November 2020\n \n \n \n \n 5 November 2020\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech to Present at 29th Annual Credit Suisse Virtual Healthcare Conference\n \n \n \n \n \n \n PureTech Health plc (LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, today announced that Daphne Zohar, founder and chief executive officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Thursday, 12 November, at 2:00 PM EST. A webcast of the presentation will be available at https://investors.puretechhealth.com.\n \n About PureTech Health\n PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and inflammatory and immunological diseases, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 24 products and product candidates, including two that have received US Food and Drug Administration (FDA) clearance and European marketing authorisation. All of the underlying programmes and platforms that resulted in this pipeline of product candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company's unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis.\n \n For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.\n \n \n Forward Looking Statement\n \n \n This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments, and strategies. The forward looking statements are based on current expect...